News
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...
1h
Free Malaysia Today on MSNAstraZeneca’s quarterly net profit jumps on record US growthThe US, a critical market for the pharmaceutical industry, accounted for 44% of AstraZeneca’s total revenue in the second ...
AstraZeneca’s revenues beat expectations for the second quarter, powered by record growth in its all-important US business.
Total revenue rose 11 per cent to $28bn (£12.98bn) in the first half of the year, driven by double-digit growth in Oncology ...
AstraZeneca pledges $50bn US investment ahead of drugs tariffs - Donald Trump is expected to announce tariffs of up to 200% ...
British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...
The FTSE 100 has started higher, up 13 points to 9,094 in a mixed early trading for European markets. Games Workshop Group ...
British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump ...
AstraZeneca ( AZN) said it is investing $50 billion in U.S. manufacturing by 2030, following the lead of big pharma peers ...
With the threat of tariffs looming for medicines imported to the United States, AstraZeneca has unveiled a plan to invest $50 ...
On a per-share basis, the Cambridge, Britain-based company said it had net income of 79 cents. Earnings, adjusted for non-recurring costs, came to $1.09 per share. The results met Wall Street ...
The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results